Topikos Logo

Innovating for a Healthier Future

Antimicrobial Organosilane Technology

Topikos Scientific pioneers in antimicrobial innovation with our advanced organosilane technology.

Our unique compounds effectively target and neutralize a wide spectrum of fungal and microbial threats. Our goal is to deliver groundbreaking treatments that bolster defense against superbugs and are effective against difficult to treat infections, improving health outcomes worldwide.

Advancing The Treatment of Biofilms

Topikos Scientific’s patented technology harnesses the power of organosilanes to offer a groundbreaking solution against biofilms and superbugs.

Our innovation offers:

Products And Pipeline

Plaque and Gingivitis Prevention & Treatment in Humans | OraMend Gel​
Status: Premarket notification under review by FDA
Treatment for Gingivitis in Animals | Gingiguard Gel​
Status: Trial
Treatment For Ear Infections​ in Animals
Status: Developmental
Burn and wound Dressing | Reduxx Gel​
Status: Developmental

Revolutionizing Dental Care in Dogs

A groundbreaking study by Topikos introduces a revolutionary antibiofilm compound, significantly advancing the treatment of periodontitis and gingivitis in dogs. This novel approach, tested on over 100 canines, showcases the potential to drastically improve dental health care in veterinary practice.

Board of Directors

President of Synthonix, maker of synthon molecules for Pharma. Inventor on '99 Organosilane patents for Emory U.
Emory's Sr. Vice Provost and chemistry professor, chairs Topikos' Scientific Board, renowned for contributions to organic chemistry.
IP law expert at KIPS, specializing in pharma & biotech patents. Recognized for elite strategy in intellectual property.
Paragon Medical founder with 30 years in aerospace, automotive, and medical devices. Expert in engineering, finance, and global leadership.

Scientific Advisory Board

FACC, FHRS, FAHA. Leads clinical research & innovation at Parkview Health; expert in medicine and academia with multiple board certifications.
Director at Topikos Biofilm Institute & Microbiology Prof. at U. St. Francis.
Vet and eco-entrepreneur, owner of Indian Creek Vet Hospital, with a focus on advanced animal treatments and founder of a green tech venture

Financial Advisory Board

CEO of Topikos Scientific, seasoned ENT surgeon, and healthcare innovator with pivotal roles in medical legislation and informatics.
Topikos Secretary/Treasurer, COO, law professor, telecom lawyer, Via-Net co-founder, and former Mayor of Del Mar, CA.
Michael Motter, CPA and seasoned executive, blends expertise in accounting with a passion for theology, evolving from public accounting to entrepreneurship.

Investor Relations